VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection
Clinical trial NCT05364242 · COMPLETED
Trial details
- NCT number
- NCT05364242
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-09
- Primary completion
- 2022-09-22
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.